RxDoctor Payments Data

Kenneth Melby

Pulmonary Disease · Decatur, GANPI 1033299144

Payments from drug & device makers

$1,889in general payments, 2019–2025

Across 118 payments — averaging $16.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$378
  • GSK$294
  • AstraZeneca$272
  • Actelion Pharmaceuticals US, Inc.$127
  • Regeneron Healthcare Solutions, Inc.$107
  • Grifols USA, LLC$97
  • plus $615 from 18 others

What the payments were for

  • Food & beverage$1,889100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,889 in reported general payments places this provider in the 30th percentile of 365 pulmonary disease providers in Georgia.

See all pulmonary disease providers in Georgia

Other pulmonary disease in Decatur

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →